Mark DePristo - designing antibodies with machine learning episode artwork

EPISODE · Feb 1, 2021 · 50 MIN

Mark DePristo - designing antibodies with machine learning

from The Bioinformatics CRO Podcast

We talk with Mark DePristo, founder and CEO of BigHat Biosciences, about building better antibody therapeutics using machine learning, overcoming the fear of failure, and the pros and cons of working in academia, for large companies like Google, and at a biotech start up.  The Bioinformatics CRO is a fully distributed contract research company that serves the computational biology needs of academic researchers and biotechnology companies, with a focus on genomics. https://www.bioinformaticscro.com/

NOW PLAYING

Mark DePristo - designing antibodies with machine learning

0:00 50:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Bioinformatics CRO Podcast?

This episode is 50 minutes long.

When was this The Bioinformatics CRO Podcast episode published?

This episode was published on February 1, 2021.

What is this episode about?

We talk with Mark DePristo, founder and CEO of BigHat Biosciences, about building better antibody therapeutics using machine learning, overcoming the fear of failure, and the pros and cons of working in academia, for large companies like Google, and...

Can I download this The Bioinformatics CRO Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!